TSHR and cancer: The development of precise and sensitive methods, such as oligonucleotide probes or microarrays, to assess TSHR levels for the design of reasonable and personalized treatment plans has emerged as crucial in the treatment of thyroid-related diseases, particularly in cancer therapy.